David Platt - 16 Jan 2024 Form 4 Insider Report for BIOXYTRAN, INC (BIXT)

Role
CEO, Director, 10%+ Owner
Signature
David Platt
Issuer symbol
BIXT
Transactions as of
16 Jan 2024
Net transactions value
+$485,904
Form type
4
Filing time
16 Jan 2024, 10:00:44 UTC
Previous filing
15 Sep 2023
Next filing
27 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIXT common stock Award $485,904 +3,599,289 +22% $0.1350 19,693,423 16 Jan 2024 by NDPD Pharma, Inc. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The total holdings in BIXT by NDPD Pharma, Inc., partly owned by officers of BIXT, are consolidated under indirect ownership in Davis Platt's filing.